Immunology and Inflammation Therapeutic Area, Type 1/17 Immunology Cluster, Sanofi, Frankfurt, Germany.
Metabolism/Imaging Mass Spectrometry Group, Drug Metabolism & Pharmacokinetics, Sanofi, Frankfurt, Germany.
Sci Rep. 2022 Jul 12;12(1):11830. doi: 10.1038/s41598-022-16005-9.
Rheumatoid arthritis (RA) is characterized by joint infiltration of immune cells and synovial inflammation which leads to progressive disability. Current treatments improve the disease outcome, but the unmet medical need is still high. New discoveries over the last decade have revealed the major impact of cellular metabolism on immune cell functions. So far, a comprehensive understanding of metabolic changes during disease development, especially in the diseased microenvironment, is still limited. Therefore, we studied the longitudinal metabolic changes during the development of murine arthritis by integrating metabolomics and transcriptomics data. We identified an early change in macrophage pathways which was accompanied by oxidative stress, a drop in NAD+ level and induction of glucose transporters. We discovered inhibition of SIRT1, a NAD-dependent histone deacetylase and confirmed its dysregulation in human macrophages and synovial tissues of RA patients. Mining this database should enable the discovery of novel metabolic targets and therapy opportunities in RA.
类风湿性关节炎(RA)的特征是免疫细胞浸润关节和滑膜炎症,导致进行性残疾。目前的治疗方法改善了疾病的预后,但仍存在未满足的医疗需求。过去十年的新发现揭示了细胞代谢对免疫细胞功能的重大影响。到目前为止,对疾病发展过程中代谢变化的全面了解,特别是在患病的微环境中,仍然有限。因此,我们通过整合代谢组学和转录组学数据,研究了在小鼠关节炎发展过程中的纵向代谢变化。我们发现了巨噬细胞途径的早期变化,伴随着氧化应激、NAD+水平下降和葡萄糖转运蛋白的诱导。我们发现了 NAD 依赖性组蛋白去乙酰化酶 SIRT1 的抑制作用,并证实了其在人类巨噬细胞和 RA 患者的滑膜组织中的失调。挖掘这个数据库应该能够发现 RA 中的新的代谢靶点和治疗机会。